Literature DB >> 3153049

Anaphylactoid purpura: characteristics of 16 patients who progressed to renal failure.

T E Bunchman1, S M Mauer, R K Sibley, R L Vernier.   

Abstract

Renal insufficiency occurs in at least 1.5% of children with anaphylactoid purpura (AP). We reviewed the records of 16 children who developed end-stage renal disease (ESRD group) secondary to AP and matched them for age, era of onset, renal histology, and clinical severity at onset with 16 children who had AP but whose creatine clearance returned to and remained normal (recovery group). We reviewed creatinine clearances at 1, 3, 5, and 10 years after onset. A creatinine clearance greater than 70 ml/min per 1.73 m2 was present in 50% of the patients in the ESRD group at 3 years and in 25% at 5 years after onset. In contrast, all patients in the recovery group had a creatinine clearance greater than 70 ml/min per 1.73 m2 by 3 years (7 of 16 had a creatinine clearance greater than 125 ml/min per 1.73 m2) and all were normal 95-125 ml/min per 1.73 m2) by 5 years. Thus, the presence of an increased creatinine clearance (greater than 125 ml/min per 1.73 m2) at 3 years predicted recovery, while failure to reach a creatinine clearance of greater than 70 ml/min per 1.73 m2 at 3 years predicted progression to ESRD. There was no evidence of recurrent systemic AP or nephritis in the 14 patients who underwent renal allograft transplantation. We conclude that long-term evaluation of patients over many years is required to identify those who will progress to ESRD from AP and that recurrence of AP in the renal transplant is uncommon.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3153049     DOI: 10.1007/bf00853428

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Anaphylactoid purpura nephritis in childhood: natural history and immunopathology.

Authors:  M Levy; M Broyer; A Arsan; D Levy-Bentolila; R Habib
Journal:  Adv Nephrol Necker Hosp       Date:  1976

2.  A possible relationship between Henoch-Schonlein syndrome and IgA nephropathy (Berger's disease). An illustrative case.

Authors:  J H Weiss; D B Bhathena; J J Curtis; B A Lucas; R G Luke
Journal:  Nephron       Date:  1978       Impact factor: 2.847

3.  Schönlein-Henoch nephritis.

Authors:  S R Meadow; E F Glasgow; R H White; M W Moncrieff; J S Cameron; C S Ogg
Journal:  Q J Med       Date:  1972-07

4.  Schoenlein-Henoch syndrome in adults. A clinical and histological study of renal involvement.

Authors:  H Bar-On; E Rosenmann
Journal:  Isr J Med Sci       Date:  1972-10

5.  Transplant biopsies and short-term outcome of cadaveric renal allografts.

Authors:  D Durand; A Segonds; C Orfila; F Degroc; P Bories; P Giraud; J M Suc
Journal:  Adv Nephrol Necker Hosp       Date:  1983

Review 6.  The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

Authors:  T H Hostetter; H G Rennke; B M Brenner
Journal:  Am J Med       Date:  1982-03       Impact factor: 4.965

7.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation.

Authors:  T H Hostetter; J L Olson; H G Rennke; M A Venkatachalam; B M Brenner
Journal:  Am J Physiol       Date:  1981-07

8.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

9.  Henoch-Schönlein nephritis: long-term prognosis of unselected patients.

Authors:  O Koskimies; S Mir; J Rapola; J Vilska
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

Review 10.  Henoch-Schönlein nephritis: prognostic features and the challenge of therapy.

Authors:  H A Austin; J E Balow
Journal:  Am J Kidney Dis       Date:  1983-03       Impact factor: 8.860

View more
  12 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  E J Tizard
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Adjuvant treatments for Henoch-Schönlein purpura nephritis in children: A systematic review.

Authors:  Marco Zaffanello; Milena Brugnara; Massimo Franchini; Vassilios Fanos
Journal:  Curr Ther Res Clin Exp       Date:  2009-06

3.  Long-term outcome of renal transplantation patients with Henoch-Schonlein purpura.

Authors:  Joyce P Samuel; Cynthia S Bell; Donald A Molony; Michael C Braun
Journal:  Clin J Am Soc Nephrol       Date:  2011-06-23       Impact factor: 8.237

4.  The role of serum myeloid-related protein 8/14 complex in Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki; Shinichirou Ohara; Yusaku Abe; Masahiro Watanabe; Kazuhide Suyama; Masatoki Sato; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

Review 5.  Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management.

Authors:  Jun-Yi Chen; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2014-12-29       Impact factor: 2.764

Review 6.  The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2011-06-23       Impact factor: 2.801

7.  Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study.

Authors:  Wen-Liang Chang; Yao-Hsu Yang; Li-Chieh Wang; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

8.  Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression.

Authors:  Mohan Shenoy; Mark G Bradbury; Malcolm A Lewis; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2007-07-24       Impact factor: 3.714

Review 9.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

10.  Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone.

Authors:  Mohan Shenoy; Milos V Ognjanovic; Malcolm G Coulthard
Journal:  Pediatr Nephrol       Date:  2007-05-26       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.